The Glasgow prognostic score predicts survival in patients with advanced non-small cell lung cancer harboring sensitive EGFR mutations who are treated with EGFR tyrosine kinase inhibitors.

Yuki Akazawa,Satoshi Igawa,Kaori Yamada,Hiroki Yamamoto,Yuri Yagami,Nobuki Kaizuka,Hiroya Manaka,Masashi Kasajima,Yoshiro Nakahara,Takashi Sato,Hisashi Mitsufuji,Masanori Yokoba,Masaru Kubota,Jiichiro Sasaki,Katsuhiko Naoki

Oncology（2023）

Cited 0|Views6

No score

Abstract

The GPS predicted the survival of NSCLC patients harboring sensitive EGFR mutations who were undergoing EGFR-TKI treatment. The GPS might be ideal for routine use in clinical practice, given that it is an easily calculated parameter.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined